文献速递皮肤肿瘤

默克尔细胞癌患者多原发癌风险:基于SEER的分析

Risk of Multiple Primary Cancers in Patients With Merkel Cell Carcinoma: A SEER-Based Analysis.
PubMed 文献 · JAMA Dermatol · 2023-01-01

IMPORTANCE: The risk of subsequent primary cancers after a diagnosis of cutaneous Merkel cell carcinoma (MCC) is not well established. OBJECTIVE: To evaluate the risk of subsequent primary cancers after the diagnosis of a first primary cutaneous MCC.…

要点

  • 甲状腺乳头状癌SIR 5.26(95%CI 3.25-8.04),非霍奇金淋巴瘤SIR 2.62(95%CI 2.04-3.32)。

核心结论

  • MCC患者后续发生实体瘤和血液系统肿瘤的风险增加。
  • 该风险增加可能与监测加强、治疗相关因素或共享病因有关。

研究设计与样本

  • 共纳入6146例首发原发性皮肤MCC患者,中位(IQR)诊断年龄76(66-83)岁,男性3713例(60.4%),非西班牙裔白人5491例(89.3%)。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: The risk of subsequent primary cancers after a diagnosis of cutaneous Merkel cell carcinoma (MCC) is not well established. OBJECTIVE: To evaluate the risk of subsequent primary cancers after the diagnosis of a first primary cutaneous MCC. DESIGN, SETTING, AND PARTICIPANTS: This cohort study analyzed data from 17 registries of the Surveillance, Epidemiology, and End Results (SEER) Program from January 1, 2000, to December 31, 2019. In all, 6146 patients diagnosed with a first primary cutaneous MCC were identified. MAIN OUTCOMES AND MEASURES: The primary outcome was the relative and absolute risks of subsequent primary cancers after the diagnosis of a first primary MCC, which were calculated using the standardized incidence ratio (SIR; ratio of observed to expected cases of subsequent cancer) and the excess risk (difference between observed and expected cases of subsequent cancer divided by the person-years at risk), respectively. Data were analyzed between January 1, 2000, and December 31, 2019. RESULTS: Of 6146 patients with a first primary MCC diagnosed at a median (IQR) age of 76 (66-83) years, 3713 (60.4%) were men, and the predominant race and ethnicity was non-Hispanic White (5491 individuals [89.3%]). Of these patients, 725 (11.8%) developed subsequent primary cancers, with an SIR of 1.28 (95% CI, 1.19-1.38) and excess risk of 57.25 per 10 000 person-years. For solid tumors after MCC, risk was elevated for cutaneous melanoma (SIR, 2.36 [95% CI, 1.85-2.97]; excess risk, 15.27 per 10 000 person-years) and papillary thyroid carcinoma (SIR, 5.26 [95% CI, 3.25-8.04]; excess risk, 6.16 per 10 000 person-years). For hematologic cancers after MCC, risk was increased for non-Hodgkin lymphoma (SIR, 2.62 [95% CI, 2.04-3.32]; excess risk, 15.48 per 10 000 person-years). CONCLUSIONS AND RELEVANCE: This cohort study found that patients with MCC had an increased risk of subsequently developing solid and hematologic cancers. This increased risk may be associated with increased surveillance, treatment-related factors, or shared etiologies of the other cancers with MCC. Further studies exploring possible common etiological factors shared between MCC and other primary cancers are warranted.

来源:JAMA Dermatol,查看原文。版权归原作者所有。

引用

  1. Eid E, Maloney NJ, Cai ZR, et al. Risk of Multiple Primary Cancers in Patients With Merkel Cell Carcinoma: A SEER-Based Analysis. JAMA Dermatol. 2023. PMID: 37703005. doi:10.1001/jamadermatol.2023.2849

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。